Compare ACFN & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACFN | VNRX |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.2M | 38.2M |
| IPO Year | N/A | N/A |
| Metric | ACFN | VNRX |
|---|---|---|
| Price | $15.79 | $0.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.17 |
| AVG Volume (30 Days) | 23.8K | ★ 2.8M |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 473.47 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $12,630,000.00 | $1,472,007.00 |
| Revenue This Year | N/A | $55.33 |
| Revenue Next Year | N/A | $493.79 |
| P/E Ratio | $6.27 | ★ N/A |
| Revenue Growth | ★ 30.11 | 14.48 |
| 52 Week Low | $12.42 | $0.27 |
| 52 Week High | $33.00 | $0.94 |
| Indicator | ACFN | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.44 | 31.94 |
| Support Level | $15.63 | $0.28 |
| Resistance Level | $17.53 | $0.31 |
| Average True Range (ATR) | 1.15 | 0.03 |
| MACD | 0.59 | 0.00 |
| Stochastic Oscillator | 65.94 | 3.40 |
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.